Table 2. The Biochemical Parameters in Blood at 0 and 12 Weeks in the Azilsartan and Olmesartan Groups.

	Azilsartan group (n = 18)			Olmesartan group (n = 20)
	0 weeks	12 weeks	P value (0 vs. 12 weeks)	0 weeks	12 weeks	P value (0 vs. 12 weeks)
UN, mg/dL	17 ± 5	18 ± 5	0.38	19 ± 6	20 ± 9	0.50
Cr, mg/dL	0.9 ± 0.2	1.0 ± 0.2	0.009	1.0 ± 0.3	1.0 ± 0.2	0.08
eGFR, mL/min/1.73 m2	63 ± 13	58 ± 12	0.003	58 ± 17	55 ± 15	0.55
UA, mg/dL	5.5 ± 1.1	5.7 ± 0.8	0.67	5.2 ± 1.1	5.9 ± 1.6	0.17
Na, mEq/L	142 ± 2	142 ± 2	0.67	141 ± 3	142 ± 3	0.64
K, mEq/L	4.3 ± 0.4	4.5 ± 0.5	0.07	4.3 ± 0.4	4.5 ± 0.4	0.30
Cl, mEq/L	105 ± 3	106 ± 3	0.12	106 ± 4	106 ± 4	0.70
LDL-C, mg/dL	85 ± 27	87 ± 38	0.70	76 ± 28	77 ± 23	0.86
HDL-C, mg/dL	47 ± 15	47 ± 12	0.80	43 ± 13	45 ± 15	0.10
TG, mg/dL	150 ± 71	144 ± 58	0.70	144 ± 86	139 ± 82	0.69
TC, mg/dL	160 ± 23	166 ± 42	0.55	146 ± 33	148 ± 30	0.64
AST, IU/L	27 ± 7	27 ± 7	0.96	27 ± 14	26 ± 12	0.60
ALT, IU/L	26 ± 9	27 ± 12	0.72	26 ± 14	24 ± 10	0.15
LDH, IU/L	202 ± 36	195 ± 28	0.39	197 ± 35	186 ± 31	0.08
CK, IU/L	132 ± 79	128 ± 58	0.80	117 ± 73	116 ± 68	0.97
Glu, mg/dL	115 ± 30	124 ± 60	0.56	121 ± 30	126 ± 38	0.51
HbA1c, %	6.6 ± 1.0	6.8 ± 1.3	0.22	7.0 ± 1.7	6.7 ± 1.5	0.36
NT-proBNP, pg/mL	114 ± 96	111 ± 104	0.90	324 ± 504	203 ± 258	0.07

UN: urea nitrogen; Cr: creatinine; eGFR: estimated glomerular filtration rate; UA: uric acid; Na: sodium; K: potassium; Cl: chloride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; TC: total cholesterol; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; CK: creatinine kinase; Glu: glucose; HbA1c: hemoglobin A1c; NT-proBNP: N-terminal pro-brain natriuretic peptide.